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Objectives: Sample preparation for high-throughput sequencing (HTS) includes treatment with various
laboratory components, potentially carrying viral nucleic acids, the extent of which has not been thor-
oughly investigated. Our aim was to systematically examine a diverse repertoire of laboratory compo-
nents used to prepare samples for HTS in order to identify contaminating viral sequences.
Methods: A total of 322 samples of mainly human origin were analysed using eight protocols, applying a
wide variety of laboratory components. Several samples (60% of human specimens) were processed using
different protocols. In total, 712 sequencing libraries were investigated for viral sequence contamination.
Results: Among sequences showing similarity to viruses, 493 were signiﬁcantly associated with the use
of laboratory components. Each of these viral sequences had sporadic appearance, only being identiﬁed
in a subset of the samples treated with the linked laboratory component, and some were not identiﬁed in
the non-template control samples. Remarkably, more than 65% of all viral sequences identiﬁed were
within viral clusters linked to the use of laboratory components.
Conclusions: We show that high prevalence of contaminating viral sequences can be expected in HTS-
based virome data and provide an extensive list of novel contaminating viral sequences that can be
used for evaluation of viral ﬁndings in future virome and metagenome studies. Moreover, we show that
detection can be problematic due to stochastic appearance and limited non-template controls. Although
the exact origin of these viral sequences requires further research, our results support laboratory-
component-linked viral sequence contamination of both biological and synthetic origin. M. Asplund,
Clin Microbiol Infect 2019;25:1277
© 2019 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology
and Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).eoGenetics, Natural History
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High-throughput sequencing (HTS) is an indispensable tool in
life science research and clinical diagnostics [1,2] and facilitates the
generation of massive amounts of DNA sequence information at
acceptable costs within a short timeframe. The ﬁeld of viromics has
beneﬁted from the rapid improvement of HTS technologies, as
evidenced by major discoveries of novel viruses [3e9], some ofof Clinical Microbiology and Infectious Diseases. This is an open access article under
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Due to high sequence diversity, it has been challenging to identify
novel viral genomes in clinical specimens using sequence-speciﬁc
molecular methods such as PCR. HTS technologies provide an
attractive alternative approach for virus discovery that require no
previous knowledge about viral genomes. However, discovery of
viruses using HTS also poses a number of challenges that must be
accounted for in the interpretation of data. Sample preparation for
HTS includes treatment with various laboratory components, also
used for sample preparation in other non-HTSmethods. Laboratory
components have previously been documented to carry viral
nucleic acid contamination [11e17]. Great caution is therefore
essential when claiming disease association with a particular
microorganism, to avoid incorrect conclusions, as in some unfor-
tunate recent examples [18e22]. A better understanding of
laboratory-component-derived contamination is needed.
Here, we systematically address the problem of nucleic acid
contamination using HTS with focus on virus identiﬁcation in
clinical samples. We provide a comprehensive in silico character-
ization of contaminating viral sequences and their probable sour-
ces. More than 300 samples were analysed using eight overall
methods applying an extensive variety of laboratory components.
The original purpose of the investigation was to identify sample-
derived viral sequences, ﬁndings described in Mollerup et al. (un-
der review). In many cases (165 out of 274 human specimens), the
same sample was processed using different laboratory protocols,
resulting in several sequencing libraries per sample. Consequently,
this study poses a unique opportunity for the characterization of
common viral artefacts and contaminants in HTS metagenomic
studies within clinical and other samples.
Methods
Ethics statement
The Regional Committee on Health Research Ethics and the
National Committee on Health Research Ethics decided that ethical
permission was not needed for collection and processing of these
samples (case no. H-2-2012-FSP2 and 1304226) according to the
Danish national legislation (Sundhedsloven). The samples used in
this study were processed anonymously. All experiments were
conducted according to the Declaration of Helsinki.
Samples
Samples consisted of 274 human specimens (32 different sam-
ple types, mostly of cancerous origin), 5 virus-spiked positive
control samples and 43 non-template controls (NTCs) (see
Supplementary material, table s1). Laboratory method develop-
ment was not part of this study and positive controls were included
to assess the bioinformatic pipeline.
Sample processing
To identify viral sequences within the samples, eight different
overall methods were used; four DNA-focused methods and four
RNA-focused methods (shotgun DNA and RNA, circular DNA
enrichment, virion enrichment DNA and RNA, mRNA enrichment,
retrovirus capture DNA and mRNA) (see Supplementary material,
Laboratory methods s1). A total of 712 sequencing libraries were
prepared and sequenced on the Illumina Hiseq 2000 platformwith
2  100 bp paired-end sequencing. For sample processing, 54
laboratory reagents and utilities (laboratory components) were
applied (see Supplementary material, ﬁg. s1 and table s2). All
samples were processed in the same laboratory.Characterization of sequencing data
Paired-end sequencing reads were adapter trimmed and quality
trimmed and merged. Reads mapping to the human reference
genome (hg38), reads <30 nucleotides in length and low-complexity
reads were excluded from further analysis. Remaining reads were
assembled into larger contiguous sequences (contigs) from a combi-
nation of pairs, collapsed (merged overlapping pairs) and singleton
reads. Default parameters were used for this purpose. Contigs and all
human depleted and quality ﬁltered reads were queried against the
NCBI nucleotide database (nt) using BLASTn (MEGABLAST) [23] with a
cut-off e-value of 103. Contigs with no BLASTn hit were queried
against the NCBI non-redundant protein database (nr) using BLASTx
with the same cut-off e-value. For each characterized sequence the
best hit was selected and taxonomically classiﬁed using the NCBI
taxonomy database. All sequences with a viral classiﬁcation were
selected and sequences with the same viral taxID at the ﬁrst level
(species/strain) were clustered. Reads possibly occurring because of
library misidentiﬁcation, as a result of mixed sequencing clusters,
referred to as bleedover [24], were considered. A bleedover ratio was
calculated by dividing the viral read count of each viral sequencewith
the highest viral read count for the same viral sequence fromdifferent
libraries sequenced on the same lane. Identiﬁed viral sequences with
bleedover ratio <0.3% were removed. Cross-contamination from one
sequencing run to another was not considered but could potentially
also be present. Hosts of viruses were recovered from the NCBI
taxonomy browser. Statistical analysis and visualization of data were
performed using the software R v. 3.5.1 [25].
Association analysis
The identiﬁed viral sequences were correlated to laboratory
components and sample types to detect possible sources of
contamination. This was done using a positive one-tailed Fisher's
exact test (signiﬁcance level a ¼ 0.05 with Bonferroni correction).
Coverage analysis
A reference genome was selected for each viral sequence linked
to a laboratory component (see Supplementary material, table s3).
Using BOWTIE2 v. 2.2.5 [26] human depleted and quality ﬁltered
reads were mapped to viral reference genomes, applying global
end-to-end and local alignment. Independently, the same reads
were mapped to six manually selected algal chloroplast genomes.
The alignments of reads to the reference genomes was visualized
using CIRCOS (v0.67-7) [27], and an additional analysis of correlation
to features based on mapping results was conducted. Cross-library
genome coverage was investigated by summing the library-speciﬁc
genome coverage of all libraries.
Results
A diversity of viral enrichment methods was applied to 279
samples of mainly human cancerous origin, resulting in 712
sequencing libraries (see Table 1).
A total of 56 728 213 824 sequencing reads were generated.
After human depletion and quality ﬁltering 2 953 972 594 reads
and 1 381 107 contigs were characterized using BLAST. The results
are summarized in Table 2 (for library-speciﬁc information see
Supplementary material, table s1).
Viral sequences linked to laboratory components
From BLAST of reads and contigs 2994 viral clusters were
identiﬁed (see Methods). Of these, signiﬁcant associations were
Table 1
Samples and libraries included in the study
Sample type Samples Shotgun
DNA
Shotgun
RNA
Virion
enrichment
Circular
DNA enrich.
Capture mRNA
enrich-ment
Libraries
DNA RNA Retro-virus
DNA
Retro-virus
mRNA
Basal cell carcinoma (cutaneous) 11 11 11 11 4 6 43
Mycosis fungoides (cutaneous) 11 11 11 11 10 11 54
Melanoma (cutaneous) 10 10 10 10 8 38
Oral cancer 10 12 10 10 10 42
Oral healthy 1 1 1
Vulvar cancer 3 3 4 3 10
Bladder cancer 7 8 9 5 22
Bladder cancer, urine 11 2 10 12
Colon cancer 32 12 11 3 3 6 6 41
Colon cancer, blood 8 8 8
Colon cancer, ascites 1 1 1 2
Colon healthy 2 2 2
Breast cancer (ductal) 10 10 10 9 13 8 50
Breast cancer (lobular) 10 10 9 10 10 7 46
Breast cancer, ascites 2 1 1 1 1 2 6
Testicular cancer (seminoma) 11 1 11 12 24
Testicular cancer (non-seminoma) 5 3 5 8 16
Testicular cancer (seminoma and non-seminoma) 4 1 4 4 9
AML 15 6 9 9 7 31
B-CLL 17 8 9 9 8 34
BCP-ALL 8 8 8 8 24
CML 20 10 10 10 10 40
T-ALL 20 9 11 11 9 40
Ovarian cancer, ascites 10 5 4 3 3 5 20
Pancreatic cancer, ascites 4 2 2 1 5
Optic neuritis, cerebrospinal ﬂuid 4 4 4
Optic neuritis, plasma 4 4 4
Vasculitis 4 4 4
Gynaecological observation, ascites 1 1 1
Cell lines 18 12 6 6 24
Positive control 5 10 2 12
NTC 20 18 5 43
Total 279 120 73 178 174 120 27 6 14 712
Abbreviations: ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia; B-CLL, B-cell chronic lymphocytic leukaemia; BCP-ALL, B-cell precursor ALL; CML, chronic
myeloid leukaemia; NTC, non-template control.
The table shows the number of samples for each sample type, the number of samples processedwith the different laboratorymethods, and the resulting number of libraries for
each sample type (rightmost column) and laboratory method (bottom line).
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hereafter referred to as laboratory-component-associated (LCA)
viral sequences (see Fig. 1 and Supplementary material, ﬁg. s2a,b
and table s4). Remarkably, 68% (62 521 069) of all viral reads
were included in viral clusters linked to laboratory components
(see Supplementarymaterial, ﬁg. s3a). For viral contigs this number
was 74% (13 687 contigs). The majority of LCA viral sequences were
non-human (see Supplementary material, ﬁg. s3b), with 60% (296/
493) being bacteriophages.
Some of the laboratory components showed high correlation
when investigating the extent of simultaneous use (see
Supplementary material, ﬁg. s4), which can explain viral sequences
showing signiﬁcant association to multiple laboratory components.
A particularly high proportion of viral sequences linked to labora-
tory components was seen for RNA-targeting overall methods (see
Supplementary material, ﬁg. s3c). Components used as part of RNATable 2
Overview of the number of sequences analysed by BLAST
Sequences analysed by BLAST
Sequences identiﬁed by BLAST
Viral sequences identiﬁed by BLAST
Bleedover depleted viral sequences
Bacterial sequences identiﬁed by BLAST
Other domain sequences identiﬁed by BLAST
Uncharacterized sequencesmethods (RNeasy MinElute, ScriptSeq v2, ScriptSeq Gold, RQ1
DNase and RQ1 Stop Solution) also showed the highest number of
linked viral sequences (see Fig. 2).In silico veriﬁcation of viral sequences linked to laboratory
components
Mapping of reads to reference genomes was conducted to
identify genome coverage and to in silico validate results from the
BLAST analysis. Both global and local alignments were performed.
The coverage of reference genomes was reported using the global
mapping results, whereas local mappingwas a complement used to
conﬁrm local BLAST hits. Cross-library genome coverage of refer-
ence genomes above 80% was seen for 13% (63/493) of LCA viral
sequences (see Supplementary material, table s5). Out of the 493
LCA viral sequences, 249 were linked to laboratory componentsReads Contigs
2 953 972 594 1 381 107
790 424 528 574 477
91 863 018 (3.1%) 18 539 (1.3%)
91 654 946 (3.1%) d
360 359 247 (12%) 411 889 (30%)
338 202 263 (11%) 144 049 (10%)
2 163 548 066 (73%) 806 628 (58%)
Fig. 1. p-values of association analysis between eukaryotic viral sequences and laboratory components at contig level. Including viral sequences linked to one or more laboratory
components (e-value <103). Signiﬁcant associations illustrated in red and non-signiﬁcant associations illustrated in blue. The strongest association(s) for each viral sequence is
marked with a black star and white stars shows multiple-source associations. Laboratory components with minimum one linked viral sequence are marked in bold font.
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(see Supplementary material, table s5). Detailed investigation of
viral clusters showed viral sequences composed of sequences
proposed to originate from the identiﬁed virus (referred to as true
viral sequences) and/or viral sequences assumed to originate from
an unknown or non-viral source (referred to as artefact viral se-
quences). The artefact viral sequences were short and regionally
repeated nucleotide sequences, generally of low complexity or
showing homology to cloning vectors or human sequences.Human host viral sequences
In total, 24 LCA viral sequences from viruses having humans as
host were identiﬁed (see Table 3 and Supplementary material,
table s4 and Results s1). These viral sequences are particularly
prone to erroneous conclusion when analysing human tissue
samples. Low genome coverage (<25%) was identiﬁed in the ma-
jority of libraries (see Supplementary material, ﬁg. s5 and table s6).
A combination of sample-derived true viral sequences and
laboratory-component-derived artefact sequences was identiﬁed
for human mast-adenovirus C, human herpesvirus 1, humanherpesvirus 5, human immunodeﬁciency virus 1, human parvo-
virus B19 and torque teno virus. Among artefact sequences we
identiﬁed homology to (i) various cloning or expression vectors
(human immunodeﬁciency virus 1, human parvovirus B19 and
Semliki Forest virus (see Supplementary material, ﬁg. s6 and
Results s1)), (ii) human sequences (human papillomavirus type
6), and (iii) ribosomal RNA sequences (Simbu virus). Other artefact
sequences did not show homology to speciﬁc types of sequences or
were identiﬁed as short low complexity sequences.Non-human vertebrate host viral sequences
We identiﬁed 60 viral sequences from viruses with a non-
human vertebrate host among LCA viral sequences (see Fig. 1 and
Supplementary material, ﬁg. s2a and table s4). Among these, 29
were avian retroviruses (predominantly from the Alpharetrovirus
genus), also including Tasmanian devil retrovirus (see
Supplementarymaterial, Results s2). The avian retroviral sequences
were linked to ScriptSeq v2 and/or ScriptSeq Gold and were iden-
tiﬁed in high proportions (median above 60%) in libraries prepared
using these methods (see Fig. 3). The cross-library genome
Fig. 2. Number of viral sequences linked to the various laboratory components. Counts comprise the number of viral sequences linked (showing the strongest association) to each
laboratory component, including viral sequences linked to more than one laboratory component because of identical p-values, and multiple source viral sequences. Bars to the left
and right show results from BLAST of reads and contigs, respectively.
M. Asplund et al. / Clinical Microbiology and Infection 25 (2019) 1277e1285 1281coverage ranged from 4% to 100% (see Supplementary material,
table s5 and circos plots s1) and 17 viral sequences showed
coverage above 60% with dispersed alignments, therefore proposed
to be true viral sequences originating from laboratory components.
The remaining avian retroviral sequences are considered artefact
viral sequences and true viral sequences present at low quantities.
From the Parvovirinae subfamily 13 viral sequences were identiﬁed.
These viral sequences showed cross-library genome coverage of
95%e100% and were all linked to the use of RNeasy MinElute, so
were proposed to be laboratory-component-derived true viral se-
quences. Four viral sequences from the Gammaretrovirus genus
linked to Nextera were identiﬁed. These showed regionally
repeated alignments with relatively low cross-library genome
coverage (7.8%e29%). The gammaretroviral sequences were, how-
ever, detected using several additional library preparationmethods
and we propose these sequences to be artefacts of unknown origin.
In addition, 14 vertebrate viral sequences from eight different viral
families were identiﬁed. Among these, Circovirus-like NI/2007-3
linked to RNeasy MinElute showed high cross-library genome
coverage (96%), proposed to be a laboratory-component-derived
true viral sequence. ASFV-like virus WU showed high cross-
library genome coverage (80%) with dispersed alignments. It is
considered a true viral sequence originating from laboratory com-
ponents. The remaining vertebrate LCAviral sequences showed low
coverage (<3%) with no or regionally repeated alignments, indi-
cating artefact viral sequences originating from laboratory
components.
Furthermore, a high number of LCA viral sequences from viruses
with non-vertebrate hosts were identiﬁed (see Fig. 1, and
Supplementarymaterial, ﬁg. s2a,b, and table s4). Among thesewere
25 algal host viral sequences, containing 14 chlorella virusesbelonging to the Chlorovirus genus, including Acanthocystis Turfa-
cea Chlorella virus (ATCV). All chlorella viral sequences were linked
to RNeasy MinElute and showed no or low cross-library genome
coverage (<5%) with dispersed and regionally repeated alignments
(see Supplementary material, table s5 and circos plots s1). Chlorella
viral sequences are proposed to be laboratory-component-derived
artefacts and true viral sequences present at low quantities. The
remaining algal viral sequences showed no or low cross-library
genome coverage (<2%) with dispersed as well as regionally
repeated alignments, indicating both artefact and true viral se-
quences originating from laboratory components. To investigate if
the presence of algal viral sequences could be explained by the
presence of algae, reads were globally mapped to six algal chloro-
plast genomes. The observed cross-library genome coverage was
6.4%e12% (see Supplementary material, circos plots s2). BLASTn of
the mapped reads against the complete NCBI nucleotide database
identiﬁed the same chloroplast genomes, thereby supporting the
presence of algal sequences in our libraries. Moreover, 18 inverte-
brate, 14 environmental, 3 fungal, 8 plant, 13 protozoan, 28 un-
known and 296 bacterial host viral sequences were identiﬁed (see
Supplementary material, Results s3).
Non-template controls
Eight of the LCA viral sequences were not detected in any of the
NTCs (see Fig. 4a). All eight were associated with the RNeasy
MinElute kit. Among LCA viral sequences detected in the NTCs, the
contaminating sequences were generally found in a higher pro-
portion in NTC libraries than template-containing libraries. We can
estimate the power to successfully detect the virus from the fre-
quency of each speciﬁc virus in the NTCs. Taking avian
Table 3
Human viral sequences linked to laboratory components
Viral sequence Blast reads/contigs
association analysis
Mapping to reference genome Evaluation of sequence origin and identity
Linked laboratory
component
p-value Nmap Alignments global mapping
(% coverage)
Cyclovirus PK6197 RNeasy MinElute 2.5E-11 1  1 region 30 bp (1.7%) LCD unknown artefact
Coxsackievirus B1 RQ1 Stop Solution 8.8E-09 0 d LCD unknown artefact
Human mast-adenovirus C QIAamp DNA 2.7E-10 151  Dispersed (0.14%e85%)
 1 region <40 bp (<0.2%)
Sample-derived true viral sequences and LCD low
complexity poly (A) artefact
Hepatitis E virus ScriptSeq Gold 2.1E-12 0 d LCD unknown artefact
Hepatitis C virus genotype 1 ScriptSeq v2 3.4E-19 537  4 regions <159 bp (<2%) LCD low complexity poly (T) artefact
Hepatitis C virus subtype 1b ScriptSeq v2 9.5E-10 533  4 regions <277 bp (<3%) LCD low complexity poly (T) artefact
Human herpesvirus 1 PCR primers II 6.7E-11 81  Dispersed (0.10%)
 3 regions <91 bp (<0.06%)
Sample-derived true viral sequences and LCD unknown
artefact
Human herpesvirus 4 ScriptSeq v2 2.5E-25 12  2 regions <42 bp (0.03%) LCD cloning vector artefact
Human herpesvirus 5 TURBO DNase 1.7E-21 43  Dispersed (0.11%, 0.30%)
 1 region <208 bp (<0.1%)
Sample-derived true viral sequences and LCD cloning
vector artefact
Human immunodeﬁciency virus 1 ScriptSeq v2 2.8E-33 113  Dispersed (11%e67%)
 3 regions <205 bp (<3%)
Sample-derived true viral sequences and LCD cloning
vector artefact
Human papillomavirus type 1a Nextera XT 6.6E-10 16  Dispersed (<4%) True viral sequences of unknown origin
Human papillomavirus type 6 PAXgene 2.0E-07 8  Dispersed (0.39%, 1.4%)
 3 regions <32 bp (<0.4%)
Human artefact
Human parvovirus B19 ScriptSeq v2 6.1E-12 41  Dispersed (0.70%e100%)
 1 region <37 bp (<0.7%)
Sample-derived true viral sequences and LCD
expression vector artefact
Human T-lymphotropic virus 1 ScriptSeq v2 2.1E-31 81  1 region <151 bp (<2%) LCD unknown artefact
Inﬂuenza A virusa Platinum Taq 2.8E-10 0 d LCD unknown artefact
Inﬂuenza A virusb ScriptSeq v2 1.2E-07 0 d LCD unknown artefact
Inﬂuenza B virusc Platinum Taq 1.2E-11 3  Dispersed (1.5%)
 1 region <40 bp (<2%)
LCD unknown artefact
Lassa virus ScriptSeq v2 7.8E-46 0 d LCD unknown artefact
Merkel cell polyomavirus Nextera XT 6.9E-17 34  Dispersed (0.76%e76%) LCD true viral sequences
Macaca mulatta polyomavirus 1 ScriptSeq Gold 1.2E-13 23  Dispersed (11%)
 2 regions <93 bp (<2%)
Cross-mapping JC polyoma-virus and LCD expression
and cloning vector artefact
Semliki Forest virus ScriptSeq Gold 5.4E-10 0 d LCD cloning vector artefact
Shamonda virus RQ1 DNase 2.3E-11 0 d LCD unknown artefact
Simbu virus RQ1 Dnase 3.2E-09 167  1 region <49 bp (0.40e0.70) LCD ribosomal RNA artefact
Torque teno virus Plasmid-Safe 1.9E-08 26  Dispersed (3.2%e96%)
 1 region <351 bp (<10%)
Sample-derived true viral sequences and bleedover
contamination
The table shows linked laboratory components and p-value of association analysis based on BLAST identiﬁcation, number of libraries in which the viral sequence was identiﬁed
by global mapping (Nmap), distribution of alignments from the global mapping, evaluation of origin (sample-derived and/or laboratory-component-derived (LCD)) and type of
sequence (true viral or artefact). For more detailed information see Supplementary material, tables s4 and s5.
a A/chicken/Karachi/NARC-100/2004(H7N3).
b A/New York/55/2004(H3N2).
c B/Thailand/CU-B2390/2010.
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virus as examples; their respective detection frequencies in NTCs
are 0.67 and 0.15. Assuming a binomial distribution, the probability
of detecting these viral sequences if running three NTCs would be
0.96 and 0.39, respectively. To reach a probability of detection>0.95
for the rodent stool-associated circular genome virus, 19 NTCs
would be necessary. Fig. 4(b) shows the number of NTCs needed for
detection of a contaminating viral sequence in one or more NTCs
with a 95% probability, illustrating the increasing number of NTCs
necessary with decreasing detection rate.
Discussion
We have here provided a comprehensive list of 493 viral se-
quences, shown to be present in a variety of sample types and NTCs,
signiﬁcantly associated with the use of one or more laboratory
components. Viral sequences showed stochastic appearance and
were only detected in a subset of the libraries treated with the
linked laboratory component, not always appearing in the NTCs.
The hosts of linked viruses were taxonomically very diverse and
included bacteria, protozoa, algae, plants, fungi, invertebrates and
vertebrates.
To our knowledge, this is the ﬁrst study using a systematic
approach to identify a wide repertoire of contaminating viralsequences and their origin. Several laboratory protocols and
different laboratory components commonly used for sample
preparation in virus discovery and surveillance with HTS were
applied to the same samples, which facilitated the identiﬁcation of
laboratory-component-derived viral sequences. This is in contrast
to other HTS studies where one laboratory practice has been
applied to samples [28].
Viral sequence contamination in clinical samples is a known
occurrence. Several viruses ﬁrst linked to disease [19,21] have later
been refuted as contamination [11,13,29,30]. In 2014, Yolken et al.
linked ATCV-1 to altered cognitive function after its detection in the
throat of healthy humans [20,31]. Subsequently, we refuted these
ﬁndings and suggested that ATCV-1 corresponded to contamina-
tion arising from one or two laboratory components used concur-
rently during library preparation [17]. In 2014, a pipeline for
identifying pathogens in HTS data from clinical samples was pre-
sented and applied to eight already published data sets originating
from samples of various disease origins [32]. Noteworthy, 7.8% (76/
974) of the viral ﬁndings in the study from 2014 were in this study
linked to laboratory components.
Among the identiﬁed viral sequences, many lacked signiﬁcant
association to laboratory components. Many of these viruses are
non-human and identiﬁcation of these would not be expected in
human cancer tissue samples. Some of the viral sequences have
Fig. 3. Avian retroviral read ratios for the different library preparation methods. The black lines illustrate the median and the red dots illustrate the average ratio of avian retroviral
reads for the different library preparation methods.
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mosaic virus [33], Gallid herpes virus, Pandoravirus, Citrobacter
phage [34] and Rotavirus [32,35,36].
More viral sequences signiﬁcantly associated with laboratory
components were identiﬁed among reads than contigs, a probable
explanation being the low depth of coverage of genomes, making
assembly of viral reads into contigs infrequent. Viral contigs were
therefore only identiﬁed in a subset of libraries and more
frequently when applying enrichment methods. This is a limitation
of our study. As enrichment methods are expected to be better for
detection of particularly low amounts of viral sequences, certain
contaminating viral sequences may be statistically linked to
enrichment-speciﬁc laboratory components because of their ability
to detect them, though potentially having a different source. A
notorious problem in HTS are reads occurring as a result of mixed
sequencing clusters, bleedover. This phenomenon could explain the
presence of speciﬁc viral sequences in NTCs (at ratios higher than
the applied bleedover threshold). Our results indicate higher
bleedover ratios in NTCs than in template-containing samples.
Non-stringent e-values as low as 103 were applied in this study to
reﬂect what is sometimes being applied in virus detection studies
[37]. However, more stringent e-values are necessary (and are be-
ing applied) when using HTS to diagnose viral infection [38].
With regard to detection of novel contaminating viral se-
quences, we rely on some degree of sequence similarity in the
BLAST identiﬁcation. This is a limitation of the analysis and further
effort could be put into identifying contaminating viral sequences
in the unidentiﬁed sequences. A sequence recurrence-based clus-
tering method has recently been published [15]. The strength of
this approach is the independence of a sequence reference database
for identiﬁcation of correlation between nucleotide sequences and
sample features.Several viral sequences with signiﬁcant association to several
laboratory components were identiﬁed. Some of the laboratory
components were used in parallel or almost in parallel, which
resulted in identical or similar p-values, making it hard to be certain
of the origin. The factual origin(s) of viral sequences could be
veriﬁed by setting up a designed experiment with different com-
binations of laboratory components and using virus-speciﬁc PCR.
This was, however, beyond the scope of this study.
Independent of the bioinformatic method used for the initial
identiﬁcation of viral sequences, we ﬁnd it of outmost importance
to evaluate genome coverage, read depth and the distribution of
alignments across the identiﬁed viral genome. A high coverage and/
or dispersed sequences across the reference genome indicate that
the viral sequences are derived from the virus in question rather
than representing an artefact. Short regionally repeated viral se-
quences in multiple samples indicate artefact viral sequences and
should always raise suspicion. Re-blasting of regionally repeated
LCA viral sequences showed additional best hits to cloning and
expression vectors, for example, Semliki Forest virus, used as a
vector for vaccine development, for gene therapy and for produc-
tion of recombinant proteins [39e41]. Others showed no additional
best hit and the artefact sequence could therefore not be identiﬁed.
The wide use of viral cloning and expression vectors could be an
overlooked problem in virus discovery, leading to false positives.
Concerning the suitability of NTCs, our main conclusion is that
several negative controls should be included in order to detect
sporadic contaminants, despite the costs of sequencing (see
Supplementary material, Discussion s1). Furthermore, we strongly
recommend that viral sequences from viruses with non-human
hosts should be handled with caution when identiﬁed in HTS
data and that researchers carefully consider the possibility of
contamination. It should be noted that viral sequences that we
Fig. 4. Non-template controls. (a) Detection rates of speciﬁc laboratory-component-associated viral sequences in non-template control (NTC) libraries and template-containing
libraries. The number of NTC libraries and template-containing libraries is shown above the bars in the ﬁgure. (b) Number of NTCs necessary to reach a detection probability of
minimum 0.95 for different viral detection rates.
M. Asplund et al. / Clinical Microbiology and Infection 25 (2019) 1277e12851284propose as contamination in human tissue samples, could have a
natural origin in samples from another species or environmental
location.
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